Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis

Eiji Ando, Masatoshi Tanaka, F Yamashita, +7

Cancer

A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients.

Yoshihiro Shimauchi, Masatoshi Tanaka, Ryoko Kuromatsu, +10

Oncology Reports

Expression of the tumor-rejection antigen SART1 in brain tumors

Toshihiro Imaizumi, Terukazu Kuramoto, Kazuko Matsunaga, +5

International Journal of Cancer

Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer

Shiro Kibe, Shigeru Yutani, Satoru Motoyama, +14

Cancer Immunology Research

ImmunologyImmunoeditingPathologyPhase Ii StudyAntigen Processing +20

A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients

Shigeru Yutani, Nobukazu Komatsu, Munehiro Yoshitomi, +8

Oncology Reports

Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination

Masanori Noguchi, Takashi Mine, Nobukazu Komatsu, +18

Cancer Biology & Therapy

ImmunologyImmunoeditingPathologyImmunotherapeuticsImmunotherapy +17

A Decrease in AFP Level Related to Administration of Interferon in Patients with Chronic Hepatitis C and a High Level of AFP

Shiro Murashima, Masatoshi Tanaka, Makoto Haramaki, +6

Digestive Diseases and Sciences

Autoimmune DiseaseHepatologyHepatitis CViral HepatitisAfp Level Related +10

Personalized peptide vaccination for advanced biliary tract cancer: IL-6, nutritional status and pre-existing antigen-specific immunity as possible biomarkers for patient prognosis

Munehiro Yoshitomi, Shigeru Yutani, Satoko Matsueda, +7

Experimental and Therapeutic Medicine

VaccinationPeptide VaccinationCancer ImmunosurveillanceVaccine PeptidesRefractory Btc +12

Radiofrequency ablation combined with transarterial chemoembolization for intermediate hepatocellular carcinoma

Masatoshi Tanaka, Eiji Ando, Shigeo Simose, +6

Hepatology Research

Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy

Shigeru Yutani, Akira Yamada, Kazumi Yoshida, +7

Vaccine

VaccinationPersonalized Peptide VaccinationVaccine DevelopmentHepatitis CHepatitis C Virus +6